The Relative Strength (RS) Rating for New York Times entered a new percentile Monday, with an increase from 79 to 83.
Hone Your Stock-Picking Skills By Focusing On These Factors
IBD's proprietary rating tracks market leadership with a 1 (worst) to 99 (best) score. The score shows how a stock's price performance over the last 52 weeks holds up against all the other stocks in our database.
History reveals that the top-performing stocks often have an RS Rating north of 80 in the early stages of their moves.
New York Times is trying to complete a consolidation with a 58.16 buy point. See if the stock can clear the breakout price in volume at least 40% above average.
New York Times reported 32% EPS growth last quarter. Revenue rose 7%.
The company earns the No. 1 rank among its peers in the Media-Newspapers industry group. News Corp Cl B and News Corp Cl A are also among the group's highest-rated stocks.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
